Yáñez Aina M, Prat Jose P, Álvarez-Sala José L, Calle Myriam, Díaz Lobato Salvador, García Gonzalez José L, Rodríguez Gonzalez-Moro José M, Galera-Martínez Raul, Villasante Carlos, Ramos Inmaculada, Franco-Gay Mercedes, de Lucas Pilar
Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
Linde Healthcare (Linde Médica), Madrid, Spain.
Respir Care. 2015 Mar;60(3):382-7. doi: 10.4187/respcare.03470. Epub 2014 Nov 25.
Portable oxygen devices simplify and facilitate patient therapy. This study was designed to compare S(pO2) and patient satisfaction with a portable oxygen concentrator or a combined system consisting of a fixed device with continuous-flow oxygen dispensation and a portable device with pulse dispensation for ambulation.
This crossover trial assessed 25 subjects with COPD (92% men, mean age of 72.2 ± 7.4 y, mean FEV1 of 34.14 ± 12.51% of predicted) at 4 hospitals in Madrid. All subjects had previously used the combined system, consisting of a fixed oxygenation system and a portable system for ambulation, with 16 (64%) using stationary and portable concentrators and 9 (36%) using a stationary reservoir and portable liquid oxygen bag. Oxygenation settings at rest and while walking were determined at baseline. Subjects were maintained on the previous combined system for 1 week and then switched to the portable oxygen concentrator for 1 week. Mean S(pO2) over 24 h was calculated using the software in the oximeter, and compliance was monitored (Visionox).
Low S(pO2) (< 90%) was significantly more frequent during use of the portable concentrator alone than with the combined system (37.1% vs 18.4%, P < .05). The portable system alone was preferred by 43% of subjects, and the combined system was preferred by 36%, whereas 21% were not sure.
Subjects preferred using a single portable oxygenation system both at home and during ambulation. Portable systems alone, however, did not supply the same levels of oxygenation as the combination of fixed and portable systems. Before the widespread adoption of portable systems as a single device, additional studies are needed to determine best-practice protocols for adjustment of daytime and nighttime oxygenation settings. (ClinicalTrials.gov registration NCT02079753).
便携式氧气设备简化并便利了患者治疗。本研究旨在比较使用便携式制氧机或由具有持续流氧供应的固定设备和用于行走的带脉冲供应的便携式设备组成的组合系统时的血氧饱和度(S(pO2))及患者满意度。
这项交叉试验在马德里的4家医院评估了25名慢性阻塞性肺疾病(COPD)患者(92%为男性,平均年龄72.2±7.4岁,平均第一秒用力呼气容积(FEV1)为预测值的34.14±12.51%)。所有受试者此前均使用过由固定氧合系统和用于行走的便携式系统组成的组合系统,其中16名(64%)使用固定式和便携式制氧机,9名(36%)使用固定式储氧器和便携式液氧袋。在基线时确定静息和行走时的氧合设置。受试者在前述组合系统上维持使用1周,然后改用便携式制氧机1周。使用血氧计中的软件计算24小时内的平均S(pO2),并监测依从性(Visionox)。
单独使用便携式制氧机时,低S(pO2)(<90%)的情况显著比使用组合系统时更频繁(37.1%对18.4%,P<.05)。43%的受试者更喜欢单独使用便携式系统,36%的受试者更喜欢组合系统,而21%不确定。
受试者在家中和行走时都更喜欢使用单一的便携式氧合系统。然而,单独的便携式系统提供的氧合水平不如固定和便携式系统的组合。在便携式系统作为单一设备广泛应用之前,需要进行更多研究以确定调整白天和夜间氧合设置的最佳实践方案。(ClinicalTrials.gov注册号NCT02079753)